Labile Plasma Iron Generation After Intravenous Iron is Time-dependent and Transitory in Patients Undergoing Chronic Hemodialysis


Autoria(s): RANGEL, Erika B.; ESPOSITO, Breno P.; CARNEIRO, Fabiana D.; MALLET, Ana Claudia; MATOS, Ana Cristina C.; ANDREOLI, Maria Claudia C.; GUIMARAES-SOUZA, Nadia K.; SANTOS, Bento F. C.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/10/2012

20/10/2012

2010

Resumo

Iron supplementation in hemodialysis patients is fundamental to erythropoiesis, but may cause harmful effects. We measured oxidative stress using labile plasma iron (LPI) after parenteral iron replacement in chronic hemodialysis patients. Intravenous iron saccharate (100 mg) was administered in patients undergoing chronic hemodialysis (N = 20). LPI was measured by an oxidant-sensitive fluorescent probe at the beginning of dialysis session (T0), at 10 min (T1), 20 min (T2), and 30 min (T3) after the infusion of iron and at the subsequent session; P < 0.05 was significant. The LPI values were significantly raised according to the time of administration and were transitory: -0.02 +/- 0.20 mu mol/L at the beginning of the first session, 0.01 +/- 0.26 mu mol/L at T0, 0.03 +/- 0.23 mu mol/L at T1, 0.09 +/- 0.28 mmol/L at T2, 0.18 +/- 0.52 mmol/L at T3, and -0.02 +/- 0.16 mmol/L (P = 0.001 to 0.041) at the beginning of the second session. The LPI level in patients without iron supplementation was -0.06 +/- 0.16 mmol/L. Correlations of LPI according to time were T1, T2, and T3 vs. serum iron (P = 0.01, P = 0.007, and P = 0.0025, respectively), and T2 and T3 vs. transferrin saturation (P = 0.001 and P = 0.0003, respectively). LPI generation after intravenous saccharate administration is time-dependent and transitorily detected during hemodialysis. The LPI increment had a positive correlation to iron and transferrin saturation.

CNPq

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

FAPESP

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Identificador

THERAPEUTIC APHERESIS AND DIALYSIS, v.14, n.2, p.186-192, 2010

1744-9979

http://producao.usp.br/handle/BDPI/31087

10.1111/j.1744-9987.2009.00786.x

http://dx.doi.org/10.1111/j.1744-9987.2009.00786.x

Idioma(s)

eng

Publicador

WILEY-BLACKWELL PUBLISHING, INC

Relação

Therapeutic Apheresis and Dialysis

Direitos

restrictedAccess

Copyright WILEY-BLACKWELL PUBLISHING, INC

Palavras-Chave #Hemodialysis #Intravenous iron #Iron #Labile plasma iron #NONTRANSFERRIN-BOUND IRON #STAGE RENAL-DISEASE #DIALYSIS PATIENTS #ACTIVE IRON #SERUM #FORMULATIONS #THERAPY #SACCHARATE #IMPAIRMENT #OVERLOAD #Hematology #Urology & Nephrology
Tipo

article

original article

publishedVersion